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ORIGINAL STUDY
Dermal C4d Deposition and Neutrophil Alignment Along
the Dermal–Epidermal Junction as a Diagnostic Adjunct for
Hypocomplementemic Urticarial Vasculitis (Anti-C1q
Vasculitis) and Underlying Systemic Disease
Jeffrey Damman, MD, PhD,* Antien L. Mooyaart, MD, PhD,* Marc A.J. Seelen, MD, PhD,†
and Martijn B.A. van Doorn, MD, PhD‡
Abstract: Urticarial vasculitis (UV) is a clinicopathologic entity
characterized by persistent urticarial lesions with biopsy features of
vasculitis. Currently, only certain clinical features such as arthral-
gia and serum complement concentrations are used to identify UV
patients at risk for an underlying systemic disease. Hypocomple-
mentemic urticarial vasculitis (HUV) is in contrast to normocom-
plementemic urticarial vasculitis (NUV), strongly associated with
underlying systemic disease, especially systemic lupus erythema-
tosus (SLE). The aim of this study was to find specific histopath-
ological features associated with HUV and underlying systemic
disease in UV. In addition, the use of complement C4d deposition
in skin biopsies was evaluated as a diagnostic adjunct for HUV-
and UV-associated systemic disease. In this retrospective study, the
clinical, histopathological, and immunohistological (C4d) features
of 43 patients with UV were compared between HUV and NUV
and analyzed for association with UV-associated systemic disease.
Eight of 43 patients with UV (19%) had hypocomplementemia.
Patients with HUV showed a significantly higher number of peri-
vascular neutrophils and lower number of eosinophils compared to
NUV. Of all histopathological features, alignment of neutrophils
along the dermal–epidermal junction (DEJ) and dermal granular
C4d deposition were found to be strongly associated with HUV and
underlying SLE. This study shows that both the alignment of
neutrophils along the DEJ and dermal C4d deposition are strongly
associated with HUV and SLE. Therefore, these (immuno)histo-
pathological features can be used as an easy diagnostic adjunct for
early detection of underlying systemic disease in UV.
Key Words: urticarial vasculitis, complement, hypocomplemente-
mia, systemic lupus erythematosus, C4d, neutrophils
(Am J Dermatopathol 2020;42:399–406)
INTRODUCTION
Urticarial vasculitis (UV) is a clinicopathologic entity
characterized by persistent urticarial lesions with biopsy
features of vasculitis. Clinically, UV is characterized by the
presence of papules or plaques with erythematous borders and
central clearing (urticarial wheals) by definition persisting for
more than 24 hours at the same location. The wheals are
usually accompanied by itch, tenderness, and/or burning pain
and tend to resolve with purpura or hyperpigmentation. The
disease is relatively rare with an estimated prevalence of 5%
of patients with chronic urticaria, mostly occurring in
women.1 Patients suffering from UV often present with
accompanying symptoms such as angioedema, arthralgia,
fever, (epi)scleritis, or uveitis. UV is regarded as a type III
hypersensitivity reaction in which (peri)vascular deposits of
immune complexes and complement fragments can be found
in the vessel wall by immunofluorescence.2 It has recently
been shown that in more than half of the patients with UV,
autoantibodies against C1q can be detected.3 Anti-C1q anti-
bodies bind to the collagenous region of C1q and activate the
classic pathway of the complement system. This is reflected
in the serum by decreased circulating levels of classical path-
way components C1q and C4 as well as C3.4 Therefore, UV
can be divided into normocomplementemic UV (NUV) and
hypocomplementemic UV (HUV) depending on serum com-
plement levels. The latter is now defined as anti-C1q vascu-
litis in the 2012 Revised International Chapel Hill consensus
Conference Nomenclature of Vasculitides.5 NUV is mostly
idiopathic but can also be triggered by certain drugs, sun
exposure, and infections such as hepatitis. By contrast,
HUV is associated with more severe disease and can indicate
the presence of an underlying systemic disease, in particular
systemic lupus erythematosus (SLE) or hypocomplementemic
urticarial vasculitis syndrome (HUVS). HUVS is character-
ized by urticaria with hypocomplementemia, arthralgia/
arthritis, glomerulonephritis, recurrent abdominal pain, and
obstructive lung disease. In all patients with HUVS, anti-
C1q antibodies can be detected.1,6–8
Histopathological examination showed classic features
of small vessel leucocytoclastic vasculitis including endo-
thelialitis, karyorrhexis, erythrocyte extravasation, and fibri-
noid necrosis. However, in practice, these features are only
found in a minority of patients with UV. Depending on the
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timing of the biopsy, histopathological features can vary
from urticarial inflammation, with a cell poor perivascular
and interstitial infiltrate of eosinophils and/or neutrophils, to
more lymphocytic inflammation. In addition, subtle features
of vascular damage are seen such as endothelialitis and
(varying degrees of) erythrocyte extravasation and karyor-
rhexis. In contrast to classic leucocytoclastic vasculitis,
fibrinoid necrosis is only present in the minority of
cases.1,2,6,7,9
At this moment, only certain clinical features and serum
measurements are used to identify UV patients at risk for an
underlying systemic disease. These features include among
others arthralgia, fever, serum complement consumption,
and antinuclear antibody (ANA) detection. The aim of this
study was to find specific histopathological features associ-
ated with HUV and underlying systemic disease. In parallel
with serum complement consumption in HUV, we investi-
gated the use of complement C4d deposition in the skin
biopsy as a diagnostic adjunct for HUV- and UV-associated
systemic disease. The results of our study could potentially
aid in an earlier diagnosis of HUV- and/or UV-associated
systemic disease.
METHODS
Patient Selection
In this retrospective study, 43 patients were included
who underwent a skin biopsy between 2010 and 2018 in the
Erasmus Medical Center Rotterdam, Rotterdam, the Nether-
lands. Patients were included when both the clinical and
histopathological criteria for UV were met and serum
complement concentrations were measured at the time of
biopsy. Demographics and clinical features were retrieved
from the medical records (Table 1). Clinical criteria for UV
were as follows: patients should present with urticarial wheals
persisting for .24 hours on the same location. Histopatho-
logical criteria for UV were as follows: vasculopathy in the
presence of lymphocytes, neutrophils, and/or eosinophils
accompanied by varying degrees of erythrocyte extravasation
and karyorrhexis. Vasculopathy was defined as the presence
inflammatory cells under the endothelium with endothelial
cell swelling and vessel wall disruption. Fibrinoid necrosis
was not required. A final diagnosis of SLE was made based
on the Systemic Lupus International Collaborating Clinics
(SLICC) criteria.
Serum Measurements
Serum complement C1q, C3, and C4 were measured
by radial immunodiffusion. ANA were detected by indirect
immunofluorescence on HEp-2 cells. ANA values of 1:80
or higher were considered positive. Anti C1q antibody
concentration in the patient with HUVS was measured by
ELISA (Sanquin, Amsterdam, the Netherlands). Patients
were divided into NUV and HUV groups based on serum
complement concentrations of C3 and C4. Hypocomple-
mentemia was defined as C3 of less than 0.9 g/L (normal
0.9–1.8 g/L) or C4 less than 0.1 g/L (normal 0.1–0.4 g/L).
Low C1q was defined as a level below 0.12 g/L (normal
0.12–0.25 g/L).
Histopathological Features and
Immunohistochemistry
Formalin-fixed paraffin-embedded tissue sections were
stained with hematoxylin and eosin for light microscopic
evaluation. Alcian blue staining was performed for evaluation
of dermal mucin deposition. Immunohistochemistry was
performed for C4d using a monoclonal antibody (SP91, Cell
marque, dilution 1:75). Histopathological features were
scored by 2 independent dermatopathologists (J.D. and
A.M.) by routine light microscopy. The inflammatory infil-
trate was scored on a nominal scale of 0–3: none (0), mild (1),
moderate (2), and profound (3). All other histopathological
parameters were scored dichotomously (yes/no).
Statistics
To compare demographics between the NUV and HUV
groups, the Mann–Whitney U test was performed for con-
tinuous variables and the Fisher exact test for categorical
variables on a nominal scale. For comparison between the
histopathological features of NUV and HUV, the Fisher exact
test was used for categorical variables on a nominal scale,
whereas x2 was used for categorical variables on an ordinal
scale. Statistical analysis was performed using SPSS (IBM
Corp. Released 2016. IBM SPSS Statistics for Windows,
Version 24.0. Armonk, NY: IBM Corp.), and 2-sided P-val-
ues of less than 0.05 were considered to indicate statistical
significance.
RESULTS
Demographics and Clinical Features
In general, the majority of patients suffering from UV
were middle-aged women with a median age of 46 years,
mostly presenting with urticarial wheals on the upper legs
(Table 1). A total number of 8 patients had low complement
concentrations (HUV), whereas 35 patients were normocom-
plementemic (NUV). Although a higher number of cases with
purpura, arthralgia, and angioedema was found in HUV com-
pared with the NUV group, this difference was not statisti-
cally significant. No appreciable difference was observed
between both baseline characteristics (age and gender) as well
as other clinical features between the NUV and HUV group.
Complement C3, C4, and C1q concentrations were (per def-
inition) significantly lower in the HUV group compared with
NUV. Serum anti-C1q antibody level in the patient with
HUVS was strongly elevated to 271 AU/mL (normal
,0.70). ANA positivity was found more frequently in the
HUV group compared with NUV (75% vs. 28%, P =
0.036). Positive ANA values of patient with HUV (n = 6)
were, respectively, 1:80, 1:160, 1:640, 1:1280, 1:2560, and
1:5120. Positive ANA values of NUV patients (n = 9) were,
respectively, 1:80 (·2), 1:160 (·3), 1:320, 1:1280 (·2), and
1:2560. Regarding the underlying cause of UV, SLE was
found to be significantly higher in HUV (50%) compared
with NUV (3%), P = 0.003.
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Histopathological Features
In general, in UV, the predominant histopathological
pattern was a mild-to-moderate superficial and deep perivas-
cular and interstitial lymphohistiocytic infiltrate admixed with
neutrophils and/or eosinophils in varying number and accom-
panied by karyorrhexis, erythrocyte extravasation, and in the
minority of cases with fibrinoid necrosis (Fig. 1 and Table 2). In
almost all cases, vasculopathy was present with lymphocytes
and histiocytes in varying number admixed with neutrophils
and eosinophils. Although the infiltrate was also found to be
located deeper in the dermis, in most cases, the infiltrate was
“top heavy” and surrounded the papillary dermal capillaries and
postcapillary venules of the superficial vascular plexus. In about
one-third of cases, the infiltrate also extended in the superficial
subcutaneous fat. Additional features were eosinophilic degran-
ulation, neutrophil alignment along the dermal–epidermal
junction (DEJ; Fig. 1), neutrophil epitheliotropism, papillary
edema, mucin deposition, and basophilic degeneration.
TABLE 1. Demographics and Disease Characteristics
Clinical Features NUV (n = 35) HUV (n = 8) P
Age 46 (31–58) 46 (34–61) 0.791†
Female 27/35 (77) 6/8 (75) 1.0*
Biopsy location 0.618‡
Hand/wrist 2 (6) 0 (0)
Arm 6 (17) 1 (13)
Shoulder 4 (11) 0 (0)
Abdomen 2 (6) 1 (13)
Upper leg 12 (34) 3 (38)
Lower leg 6 (17) 2 (25)
Knee 1 (3) 0 (0)
Foot 1 (3) 0 (0)
Back 0 (0) 1 (13)
Unknown 1 (3) 0 (0)
Wheals .24 h 35/35 (100) 8/8 (100) N.A.
Residual hyperpigmentation 17/20 (85) 3/3 (100) 0.644*
Purpura 6/27 (22) 3/6 (50) 0.123*
Itch 28/33 (85) 6/8 (75) 0.606*
Pain or burning sensation 23/31 (74) 5/7 (71) 1.0*
Arthralgia 13/33 (39) 4/6 (67) 0.374*
Fever 8/32 (25) 2/6 (33) 0.644*
Angioedema 13/32 (41) 5/7 (71) 0.215*
Laboratory measurements
Complement C3 (g/L) 1.3 (1.13–1.46) (34/35) 0.49 (0.32–0.61) (8/8) ,0.001†
Complement C4 (g/L) 0.25 (0.31–0.26) (32/35) 0.08 (0.04–0.13) (7/8) ,0.001†
Complement C1q (g/L) 0.22 (0.21–0.26) (23/35) 0.1 (3/8) 0.005†
ANA 9/32 (28) 6/8 (75) 0.036†
Associated condition
Systemic lupus erythematosus 1 (3) 4 (50) 0.003*
HUVS 0 (0) 1 (13)
Idiopathic retroperitoneal fibrosis,
B-cell clone
0 (0) 1 (13)
Relapsing polychondritis 1 (3) 1 (13)
Infectious 1 (3) 0
FMF 1 (3) 0
Drugs 1 (3) 0
ANCA-negative GPA 1 (3) 0
Crohn disease, arthritis 1 (3) 0
Idiopathic 28 (80) 1 (13)
Age data is expressed as median (interquartile range), all other data (except for laboratory measurements) are expressed as positive numbers (%). All P‐values are 2‐sided.
*Fisher exact test.
†Mann–Whitney test.
‡x2 test.
ANCA, antineutrophilic cytoplasmic autoantibody; FMF, Familial Mediterranean Fever; GPA, granulomatosis with polyangiitis; N.A., not applicable.
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In HUV, the perivascular and interstitial neutrophil
infiltration was more extensive compared with NUV, reach-
ing statistical significance in the perivascular component
(P = 0.047, Fig. 1). Also, in the vasculopathic component,
the neutrophil count was higher in HUV versus NUV, but
this was not statistically significant (P = 0.083). In HUV, the
perivascular and interstitial eosinophilic infiltrate was less
extensive compared with NUV, reaching statistical signifi-
cance for the interstitial component (P = 0.035). The degree
of erythrocyte extravasation and nuclear dust was higher in
HUV versus NUV, of which nuclear dust reached statistical
significance (P = 0.049). The strongest association of this
study was the finding of neutrophil alignment along the DEJ,
which was found in 75% of the HUV cases compared with
17% in NUV cases (Fig. 1). All other histopathological fea-
tures were similar for the HUV and NUV groups. None of
our patients showed features of interface dermatitis.
C4d Analysis
Dermal C4d deposition was significantly higher in
a granular pattern on and between the perivascular infiltrate
in HUV versus NUV (Figs. 2A, B, P , 0.001). Although the
number of vessels with linear vascular and sometimes gran-
ular C4d deposition was higher in HUV versus NUV, this
difference was not statistically significant (Figs. 2C, D, P =
0.091). Also, the intensity of vascular C4d deposition was
similar between both groups (P = 0.540). None of our patients
showed a granular C4d deposition along the basement
membrane.
We also investigated the direct association of
neutrophil alignment along the DEJ and C4d positivity
with SLE and compared this in terms of sensitivity,
specificity, and positive and negative predictive values
(Table 3) We found that hypocomplementemia in UV is
most strongly associated with SLE. The sensitivity of
HUV for SLE is 80%, and the specificity is increased from
FIGURE 1. A, A case of neutrophilic urticarial vasculitis with extensive erythrocyte extravasation. A different case of NUV (B)
shows an example of lymphocytic vasculopathy with influx of lymphocytes and neutrophils under the endothelium sur-
rounded by nuclear dust and extravasated erythrocytes. C, A case of HUV with alignment of neutrophils along the DEJ
(arrows).
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TABLE 2. Histopathological Features in NUV and HUV
NUV
(n = 35)
HUV
(n = 8) P
Infiltrate architecture
Superficial perivascular 34 (97) 8 (100) 1.0*
Deep perivascular 33 (94) 7 (88) 0.470*
Superficial interstitial 33 (94) 7 (88) 0.470*
Deep interstitial 30 (86) 6 (75) 0.587*
Subcutaneous fat
(if present)
No: 5 (14) No: 3 (38) 0.259†
Yes: 13 (37) Yes: 3 (38)
Perivascular
Total:
Mild 10 (29) 1 (13) 0.639†
Moderate 21 (60) 6 (75)
Profound 4 (11) 1 (13)
Lymphocytes:
None 1 (3) 0 (0) 0.578†
Mild 17 (49) 6 (75)
Moderate 16 (46) 2 (25)
Profound 1 (3) 0 (0)
Histiocytes:
None 2 (6) 0 (0) 0.752†
Mild 23 (66) 6 (75)
Moderate 10 (29) 2 (25)
Profound 0 (0) 0 (0)
Neutrophils:
None 1 (3) 0 (0) 0.047†
Mild 22 (63) 1 (13)
Moderate 9 (26) 6 (75)
Profound 3 (9) 1 (13)
Eosinophils
None 4 (11) 1 (13) 0.193†
Mild 23 (66) 5 (63)
Moderate 8 (23) 1 (13)
Profound 0 (0) 1 (13)
Interstitial
Total:
None 2 (6) 1 (13) 0.182†
Mild 23 (66) 2 (25)
Moderate 9 (26) 4 (50)
Profound 1 (3) 1 (13)
Lymphocytes:
None 4 (11) 2 (25) 0.443†
Mild 29 (83) 5 (63)
Moderate 2 (6) 1 (13)
Profound 0 (0) 0 (0)
Histiocytes:
None 2 (6) 2 (25) 0.103†
Mild 32 (91) 5 (63)
Moderate 1 (3) 1 (13)
Profound 0 (0) 0 (0)
Neutrophils:
None 6 (17) 1 (13) 0.108†
Mild 22 (63) 2 (25)
Moderate 6 (17) 4 (50)
Profound 1 (3) 1 (13)
TABLE 2. (Continued ) Histopathological Features in NUV and
HUV
NUV
(n = 35)
HUV
(n = 8) P
Eosinophils:
None 7 (20) 4 (50) 0.035†
Mild 24 (69) 3 (37)
Moderate 4 (11) 0 (0)
Profound 0 (0) 1 (13)
Vasculopathy
Total 33 (94) 8 (100) 1.0 *
Lymphocytes 30 (91) 8 (100) 1.0 *
Histiocytes 29 (88) 7 (88) 1.0 *
Neutrophils 22 (67) 8 (100) 0.083*
Eosinophils 15 (46) 4 (50) 1.0*
Vessels
Fibrinoid necrosis 4 (11) 2 (25) 0.308*
Erythrocyte extravasation:
None 7 (20) 0 (0) 0.074†
Mild 19 (54) 6 (75)
Moderate 9 (26) 1 (13)
Profound 0 (0) 1 (13)
Additional features
Eosinophilic degranulation:
None 9 (26) 3 (38) 0.479†
Mild 21 (60) 5 (63)
Moderate 5 (14) 0 (0)
Profound 0 (0) 0 (0)
Nuclear dust
None 0 (0) 0 (0) 0.049†
Mild 25 (71) 2 (25)
Moderate 8 (23) 5 (63)
Profound 2 (6) 1 (13)
Neutrophil epitheliotropism 3 (9) 2 (25) 0.228*
Neutrophils along the DEJ 6 (17) 7 (88) ,0.001*
Papillary edema 4 (11) 1 (13) 1.0*
Mucin deposition (alcian blue): 0.904†
None 16/31 (52) 4/8 (50)
Mild 12/31 (39) 3/8 (38)
Moderate 2/31 (7) 1/8 (13)
Profound 1/31 (3) 0/8 (0)
Basophilic degeneration 12 (34) 5 (63) 0.230*
C4d positivity
Dermal granular 4/32 (13) 7/8 (88) ,0.001*
Vessel number: 0.091†
None 8/32 (25) 1/8 (13)
1%–5% 16/32 (50) 2/8 (25)
5%–25% 6/32 (19) 2/8 (25)
.25% 2/32 (6) 3/8 (38)
Vessel intensity: 0.540†
None 8/32 (25) 1/8 (13)
Mild 12/32 (38) 3/8 (38)
Moderate 9/32 (29) 4/8 (50)
Profound 3/32 (9) 0/8 (0)
All data are expressed as positive numbers (%). All P‐values are 2‐sided.
*Fisher exact test.
†x2 test.
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89% to 95% when combined with ANA values. Both neu-
trophils along the DEJ and C4d show lower specificity,
also when combined with HUV and/or ANA values (data
not shown). Analysis for C4d was performed only for 4 of
5 SLE patients because in one case, there was not enough
material left for proper C4d staining.
DISCUSSION
UV is a rare disease in which patients present with
persistent urticarial lesions at the same location with biopsy
features of vasculitis. UV can be idiopathic, infection- or
drug-induced, or a manifestation of an underlying systemic
disease such as SLE, Sjögren syndrome, or malignancy. At
this moment, only few clinical features such as arthralgia and
fever as well as serum complement measurements are used to
identify UV patients at risk for an underlying systemic dis-
ease. HUV is in contrast to NUV, strongly associated with
underlying systemic disease, especially SLE. In addition to
clinical signs of HUV, the aim of this study was to find
histopathological features associated with HUV- or UV-
associated systemic disease. Besides, we also investigated
the use of complement C4d deposition in the skin biopsy as
a diagnostic adjunct. The main finding of our study is that
both alignment of neutrophils along the DEJ and dermal C4d
deposition are strongly associated with HUV and SLE.
Clinically, UV can be distinguished from chronic
spontaneous urticaria by the presence of unprovoked urticar-
ial wheals that persist for .24 hours at the same site and have
a tendency to heal with residual purpura and/or hyperpigmen-
tation. UV is regarded as a type III hypersensitivity reaction
in which immune complexes are deposited in the skin fol-
lowed by activation of the classic pathway of complement.
Subsequently, C4 and C3 are activated leading to the release
of C5a and ultimately to the formation of the membrane
attack complex C5b-9.2,10 C5a has strong chemotactic
FIGURE 2. Granular dermal C4d deposition in HUV in a patient with underlying systemic lupus erythematosus (A and B). C4d is
deposited in a granular fashion on and between the perivascular neutrophilic infiltrate in HUV, reflecting classic complement
activation after immune complex deposition. Granular vascular endothelial C4d deposition (C, arrows) and strong continuous
C4d deposition (D) in postcapillary venules in a patient with HUV.
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properties for neutrophils but can also act on mast cells to
release histamine, chemokines, cytokines, and other vasodi-
latory substances.10 Due to the increased vascular permeabil-
ity, both vascular and extravascular immune complex
deposition is permitted. Both immunoglobulins and C3 have
been found by immunofluorescence on vascular endothelium
as well as granular deposition in the basement membrane
zone in the case of underlying SLE. Based on the level of
complement activation, clinical features can differ from NUV
only showing urticarial lesions, HUV showing urticarial le-
sions more frequently associated with systemic involvement,
and HUVS which is associated with severe systemic disease
and multiorgan involvement. It is likely that both the level
and nature of circulating antibodies directly influence the
level of complement activation and severity of the disease.
Antibodies can be directed against autologous antigens (auto-
antibodies against self-antigens) or exogenous antigens (eg,
infective agents and drugs). C1q autoantibodies against the
collagen region of C1q can be found in more than 50% of
patients with HUV and in 100% of HUVS. A large part of this
can be explained by the high number of SLE patients in this
group. This raises the question whether SLE and HUV(S)
could represent different expressions of the same disease.
The current study is the most extensive histopatholog-
ical study on UV including many additional histopathological
features known to be associated with systemic disease.
Similar to previous studies, we found that a neutrophil-
predominant dermal infiltrate is associated with
HUV.6,7,9,11,12 In addition to previous publications, we also
scored a substantial number of additional histopathological
features. In our study, the strongest histopathological feature
associated with HUV is the presence of neutrophils along the
DEJ and local dermal C4d deposition. Besides association
with HUV, neutrophil DEJ and dermal C4d deposition were
also directly associated with SLE (Table 3). As markers for
SLE, hypocomplementemia alone or combined with ANA
levels shows superior sensitivity and specificity over histo-
pathological features, also when these features were added to
both parameters. However, irrespective of serum measure-
ment, our findings can prompt the dermatopathologist when
faced with these (immuno)histopathological features to sug-
gest an association with an underlying systemic disease in
UV. Alignment of neutrophils along the DEJ has been
described for bullous SLE and more recently in neutrophilic
urticarial dermatosis and so-called “autoimmunity-related
neutrophilic dermatosis.”13,14 In contrast to the previous enti-
ties, we are the first to report this histopathological clue in
UV. Moreover, our findings further strengthen the hypothesis
that SLE and HUV represent different expression of the same
disease.15,16
In SLE-associated HUV, immunoglobulins and C3 can
be found in a granular fashion in the (peri)vascular endothe-
lium and along the basement membrane (lupus-band) by
immunofluorescence.16 The presence of immunoglobulins
along the basement membrane can likely explain our findings
of neutrophils along the DEJ. Our study also shows vascular
but predominantly perivascular granular C4d deposition on
and between the infiltrate, reflecting immune-complex–
mediated classic complement activation. Immunoglobulins
are known to have a relatively short half-life on the endothe-
lium and are only found in a minority of cases by direct
immunofluorescence in UV. C4d is a split product of C4
and thereby reflects prior antibody-mediated activation of
the classic complement pathway. The detection of C4d has
been extensively used as a marker of antibody-mediated
rejection after kidney transplantation. C4d itself is biologi-
cally inactive, but has a long half-life and therefore serves
as an excellent marker of prior or ongoing complement acti-
vation. At this moment, it is the only antibody against a com-
plement component that is routinely used on formalin-fixed
paraffin-embedded tissue and can therefore easily be used in
clinical practice instead of direct immunofluorescence on fro-
zen tissue. It allows clinicians to proceed directly to serolog-
ical investigation of an underlying systemic disease.
In summary, the current study shows that both the
alignment of neutrophils along the DEJ and dermal C4d
deposition are strongly associated with HUV and SLE.
Therefore, these (immuno)histopathological features can be
used as an easy diagnostic adjunct for early detection of
underlying systemic disease in UV.
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